Rachel Slottke
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 6
- PARP inhibition in cancer therapy 1
-
- Prostate Cancer Treatment and Research 9
-
- Immunotherapy and Immune Responses 3
-
- Cancer Genomics and Diagnostics 2
-
- Genomics, phytochemicals, and oxidative stress 2
- Protein Degradation and Inhibitors 1
-
- Bioactive Compounds and Antitumor Agents 1
Rachel Slottke
13 papers receiving 770 citations
Peers
Comparison fields: 5 of 70
- Oncology 345
- Pulmonary and Respiratory Medicine 388
- Immunology 215
- Cancer Research 148
- Molecular Biology 344
Countries citing papers authored by Rachel Slottke
This map shows the geographic impact of Rachel Slottke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Slottke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Slottke more than expected).
Fields of papers citing papers by Rachel Slottke
This network shows the impact of papers produced by Rachel Slottke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Slottke. The network helps show where Rachel Slottke may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rachel Slottke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 36 | |
| 2 | 2022 | 2 | |
| 3 | 2020 | 87 | |
| 4 | 2019 | 5 | |
| 5 | 2018 | 27 | |
| 6 | 2017 | 68 | |
| 7 | 2017 | 20 | |
| 8 | 2016 | 27 | |
| 9 | 2016 | 262 | |
| 10 | 2015 | 11 | |
| 11 | 2014 | 167 | |
| 12 | 2013 | 4 | |
| 13 | 2009 | 66 |
About Rachel Slottke
Rachel Slottke is a scholar working on Oncology, Toxicology and Pulmonary and Respiratory Medicine, having authored 13 papers that have together received 782 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (9 papers), Cancer Immunotherapy and Biomarkers (6 papers), Immunotherapy and Immune Responses (3 papers), Genomics, phytochemicals, and oxidative stress (2 papers), Cancer Genomics and Diagnostics (2 papers), Bioactive Compounds and Antitumor Agents (1 paper), PARP inhibition in cancer therapy (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Oncology (345 citations), Pulmonary and Respiratory Medicine (388 citations) and Immunology (215 citations). Rachel Slottke has collaborated with scholars based in United States. Frequent co-authors include Joshi J. Alumkal, Tomasz M. Beer, Julie N. Graff, George Thomas, Charles G. Drake, William L. Redmond, Raymond C. Bergan, Mohammad Farhad, Jeremy Cetnar and Amy E. Moran. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.